Developing Medicines in Line with Global Public Health Needs: The Role of the World Health Organization

被引：1
作者：
Pang, Tikki [1 ,2 ]
机构：
[1] WHO, New York, NY 10017 USA
[2] Univ Malaya, Kuala Lumpur, Malaysia
来源：
CAMBRIDGE QUARTERLY OF HEALTHCARE ETHICS | 2011年 / 20卷 / 02期
关键词：
D O I：
10.1017/S0963180110000940
中图分类号：
R19 [保健组织与事业（卫生事业管理）];
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：290 / 297
页数：8
相关论文
共 13 条
[1]  
[Anonymous], PUBL HLTH INN INT PR
[2]   Global framework on essential health R&D [J].
Chirac, P ;
Torreele, E .
LANCET, 2006, 367 (9522) :1560-1561
[3]  
*EXP WORK GROUP RE, 2009, PUBL HLTH INN INT PR, P16
[4]   Selected major risk factors and global and regional burden of disease [J].
Ezzati, M ;
Lopez, AD ;
Rodgers, A ;
Vander Hoorn, S ;
Murray, CJL .
LANCET, 2002, 360 (9343) :1347-1360
[5]  
*MED MAL VENT, PYR DOSS UNPUB
[6]  
*OXF AUSTR, GEND EQ
[7]  
Pogge T, 2007, CAMB Q HEALTHC ETHIC, V16, P97
[8]  
Selgelid MichaelJ., 2006, POWER PILLS SOCIAL E, P153
[9]  
*WHO, 2008, GLOB STRAT PLAN ACT
[10]  
*WHO, BACKGR GLOB STRAT PL
12